Importantly, MeRIP-qPCR and RIP-qPCR results revealed that m6A and IGF2BP2 antibodies significantly enriched FBXO43 mRNA in HCC cells, respectively (Figure 3B,C), indicating that m6A modification of FBXO43, recognized by IGF2BP2, could regulate its expression in HCC. Here, IGF2BP2 is linked to hepatocellular carcinoma.